Off-Label Use of Hospira Potassium Phosphate Injections On Infants Carries Aluminum Toxicity Risks: FDA Warns
The FDA is warning doctors not to prescribe Hospira potassium phosphate injections to infants, due to the risk of aluminum toxicity.
The FDA is warning doctors not to prescribe Hospira potassium phosphate injections to infants, due to the risk of aluminum toxicity.